Download PDF
CC BY-NC-ND 4.0 · Rev Bras Ortop (Sao Paulo) 2021; 56(05): 621-627
DOI: 10.1055/s-0041-1729941
Artigo de Atualização
Infectologia

Infecção após artroplastia total primária de joelho: estudo randomizado prospectivo controlado da adição de antibiótico ao cimento ósseo[*]

Article in several languages: português | English
Hugo Alexandre de Araujo Barros Cobra 
1   Centro de Atenção Especializada em Cirurgia do Joelho, Instituto Nacional de Traumatologia e Ortopedia, Rio de Janeiro, RJ, Brasil
,
Alan de Paula Mozella 
1   Centro de Atenção Especializada em Cirurgia do Joelho, Instituto Nacional de Traumatologia e Ortopedia, Rio de Janeiro, RJ, Brasil
,
Pedro José Labronici 
2   Departamento de Ortopedia e Traumatologia, Universidade Federal Fluminense, Niterói, RJ, Brasil
,
Amanda S. Cavalcanti    *
3   Divisão de Pesquisa, Instituto Nacional de Traumatologia e Ortopedia, Rio de Janeiro, RJ, Brasil
,
João Antonio Matheus Guimarães 
3   Divisão de Pesquisa, Instituto Nacional de Traumatologia e Ortopedia, Rio de Janeiro, RJ, Brasil
› Author Affiliations
› Further Information
   Permissions and Reprints

Resumo

Objetivo O presente estudo prospectivo, randomizado e controlado foi realizado com 286 pacientes submetidos à artroplastia total primária do joelho (ATJ) com o objetivo de avaliar a eficácia da adição de antibiótico ao cimento ósseo como forma de prevenção da infecção pós-artroplastia (IPA).

Métodos Os pacientes foram randomizados em dois grupos: cimento ósseo sem antibiótico (Sem ATB, n = 158) ou cimento com antibiótico (Com ATB, n = 128), ao qual foram adicionados 2 g de Vancomicina para 40 g de cimento. Os pacientes foram acompanhados por 24 meses após a cirurgia.

Resultados No que diz respeito aos dados demográficos pré-operatórios, a distribuição dos pacientes entre os grupos foi homogênea (p < 0,05). No período de 24 meses, a taxa global de infecção foi de 2,09% (6/286), não havendo diferença (odds ratio [OR] = 1,636; intervalo de confiança [IC] 95%: 0,294–9,080; p = 0,694) entre o grupo Com ATB (1,56%; 2/128) e Sem ATB (2,53%; 4/158). No grupo Sem ATB, a infecção foi causada por Staphylococcus aureus resistente à meticilina (MRSA, na sigla em inglês) (n = 2), S. aureus sensível à meticilina (MSSA, na sigla em inglês) (n = 1) e Eschirichia coli (n = 1). Proteus mirabilis e MSSA foram isolados dos pacientes do grupo Com ATB. Dentre as comorbidades, todos os pacientes com IPA eram hipertensos e não diabéticos. Dois pacientes com artrite reumatoide que desenvolveram IPA eram do grupo Com ATB.

Conclusão O uso de cimento com ATB reduziu o número absoluto de infecções; porém, sem diferença estatística entre os grupos. Desta forma, o uso rotineiro não deve ser encorajado.

Palavras-chave

antibiótico - artroplastia do joelho - cimentos ósseos - infecções relacionadas à prótese

* Trabalho desenvolvido no Instituto Nacional de Traumatologia e Ortopedia (INTO), Rio de Janeiro, RJ, Brasil.


Supplementary Material



Publication History

Received: 27 July 2020

Accepted: 01 December 2020

Article published online:
28 October 2021

© 2021. Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 

  • Referências

  • 1 Laffer RR, Graber P, Ochsner PE, Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006; 12 (05) 433-439
    CrossrefPubMedGoogle Scholar
  • 2 Daines BK, Dennis DA, Amann S. Infection prevention in total knee arthroplasty. J Am Acad Orthop Surg 2015; 23 (06) 356-364
    CrossrefPubMedGoogle Scholar
  • 3 Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA. Current Epidemiology of Revision Total Knee Arthroplasty in the United States. J Arthroplasty 2017; 32 (09) 2663-2668
    CrossrefPubMedGoogle Scholar
  • 4 Cobra H. Causas de falha de artroplastia total de joelho. Rev INTO. 2009; 7 (04) 11-18
    Google Scholar
  • 5 Qadir R, Sidhu S, Ochsner JL, Meyer MS, Chimento GF. Risk stratified usage of antibiotic-loaded bone cement for primary total knee arthroplasty: short term infection outcomes with a standardized cement protocol. J Arthroplasty 2014; 29 (08) 1622-1624
    CrossrefPubMedGoogle Scholar
  • 6 Frazão VL, Miyahara HS, Kirihara RA, Lima ALLM, Croci AT, Vicente JRN. Social profile and cost analysis of deep infection following total hip replacement surgery. Rev Bras Ortop 2017; 52 (06) 720-724
    Google Scholar
  • 7 Abdelaziz H, von Förster G, Kühn KD, Gehrke T, Citak M. Minimum 5 years' follow-up after gentamicin- and clindamycin-loaded PMMA cement in total joint arthroplasty. J Med Microbiol 2019; 68 (03) 475-479
    CrossrefPubMedGoogle Scholar
  • 8 Hansen EN, Adeli B, Kenyon R, Parvizi J. Routine use of antibiotic laden bone cement for primary total knee arthroplasty: impact on infecting microbial patterns and resistance profiles. J Arthroplasty 2014; 29 (06) 1123-1127
    CrossrefPubMedGoogle Scholar
  • 9 Fleischman AN, Austin MS. Local Intra-wound Administration of Powdered Antibiotics in Orthopaedic Surgery. J Bone Jt Infect 2017; 2 (01) 23-28
    CrossrefPubMedGoogle Scholar
  • 10 Chiu FY, Chen CM, Lin CF, Lo WH. Cefuroxime-impregnated cement in primary total knee arthroplasty: a prospective, randomized study of three hundred and forty knees. J Bone Joint Surg Am 2002; 84 (05) 759-762
    CrossrefPubMedGoogle Scholar
  • 11 Chen AF, Fleischman A, Austin MS. Use of Intrawound Antibiotics in Orthopaedic Surgery. J Am Acad Orthop Surg 2018; 26 (17) e371-e378
    CrossrefPubMedGoogle Scholar
  • 12 McLaren AC, Nugent M, Economopoulos K, Kaul H, Vernon BL, McLemore R. Hand-mixed and premixed antibiotic-loaded bone cement have similar homogeneity. Clin Orthop Relat Res 2009; 467 (07) 1693-1698
    CrossrefPubMedGoogle Scholar
  • 13 Sanz-Ruiz P, Matas-Diez JA, Sanchez-Somolinos M, Villanueva-Martinez M, Vaquero-Martín J. Is the Commercial Antibiotic-Loaded Bone Cement Useful in Prophylaxis and Cost Saving After Knee and Hip Joint Arthroplasty? The Transatlantic Paradox. J Arthroplasty 2017; 32 (04) 1095-1099
    CrossrefPubMedGoogle Scholar
  • 14 King JD, Hamilton DH, Jacobs CA, Duncan ST. The Hidden Cost of Commercial Antibiotic-Loaded Bone Cement: A Systematic Review of Clinical Results and Cost Implications Following Total Knee Arthroplasty. J Arthroplasty 2018; 33 (12) 3789-3792
    CrossrefPubMedGoogle Scholar
  • 15 Parvizi J, Zmistowski B, Berbari EF. et al. New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011; 469 (11) 2992-2994
    CrossrefPubMedGoogle Scholar
  • 16 Parvizi J, Della Valle CJ. AAOS Clinical Practice Guideline: diagnosis and treatment of periprosthetic joint infections of the hip and knee. J Am Acad Orthop Surg 2010; 18 (12) 771-772
    CrossrefPubMedGoogle Scholar
  • 17 Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010; 468 (01) 52-56
    CrossrefPubMedGoogle Scholar
  • 18 Gandhi R, Razak F, Pathy R, Davey JR, Syed K, Mahomed NN. Antibiotic bone cement and the incidence of deep infection after total knee arthroplasty. J Arthroplasty 2009; 24 (07) 1015-1018
    CrossrefPubMedGoogle Scholar
  • 19 Namba RS, Inacio MC, Paxton EW. Risk factors associated with deep surgical site infections after primary total knee arthroplasty: an analysis of 56,216 knees. J Bone Joint Surg Am 2013; 95 (09) 775-782
    CrossrefPubMedGoogle Scholar
  • 20 Chiu FY, Lin CF, Chen CM, Lo WH, Chaung TY. Cefuroxime-impregnated cement at primary total knee arthroplasty in diabetes mellitus. A prospective, randomised study. J Bone Joint Surg Br 2001; 83 (05) 691-695
    CrossrefPubMedGoogle Scholar
  • 21 Namba RS, Chen Y, Paxton EW, Slipchenko T, Fithian DC. Outcomes of routine use of antibiotic-loaded cement in primary total knee arthroplasty. J Arthroplasty 2009; 24 (6 Suppl): 44-47
    CrossrefPubMedGoogle Scholar
  • 22 Wang J, Zhu C, Cheng T. et al. A systematic review and meta-analysis of antibiotic-impregnated bone cement use in primary total hip or knee arthroplasty. PLoS One 2013; 8 (12) e82745
    CrossrefPubMedGoogle Scholar
  • 23 Dowsey MM, Choong PF. Obese diabetic patients are at substantial risk for deep infection after primary TKA. Clin Orthop Relat Res 2009; 467 (06) 1577-1581
    CrossrefPubMedGoogle Scholar
  • 24 Jämsen E, Nevalainen P, Eskelinen A, Huotari K, Kalliovalkama J, Moilanen T. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis. J Bone Joint Surg Am 2012; 94 (14) e101
    CrossrefPubMedGoogle Scholar
  • 25 Cross MB, Yi PH, Thomas CF, Garcia J, Della Valle CJ. Evaluation of malnutrition in orthopaedic surgery. J Am Acad Orthop Surg 2014; 22 (03) 193-199
    CrossrefPubMedGoogle Scholar
  • 26 Rezapoor M, Parvizi J. Prevention of periprosthetic joint infection. J Arthroplasty 2015; 30 (06) 902-907
    CrossrefPubMedGoogle Scholar
  • 27 Waitzberg DL, Caiaffa WT, Correia MI. Hospital malnutrition: the Brazilian national survey (IBRANUTRI): a study of 4000 patients. Nutrition 2001; 17 (7-8): 573-580
    CrossrefPubMedGoogle Scholar
  • 28 Kim S, Bishop AR, Squire MW, Rose WE, Ploeg HL. Mechanical, elution, and antibacterial properties of simplex bone cement loaded with vancomycin. J Mech Behav Biomed Mater 2020; 103: 103588
    CrossrefPubMedGoogle Scholar
  • 29 Cram P, Lu X, Kates SL, Singh JA, Li Y, Wolf BR. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991-2010. JAMA 2012; 308 (12) 1227-1236
    CrossrefPubMedGoogle Scholar
  • 30 Parvizi J, Tan TL, Goswami K. et al. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty 2018; 33 (05) 1309-131 4.e2
    CrossrefPubMedGoogle Scholar
  • 31 Dal-Paz K, Oliveira PR, Paula AP, Emerick MC, Pécora JR, Lima AL. Economic impact of treatment for surgical site infections in cases of total knee arthroplasty in a tertiary public hospital in Brazil. Braz J Infect Dis 2010; 14 (04) 356-359
    CrossrefPubMedGoogle Scholar